# Otsuka Pharmaceutical Co., Ltd.

Organization · id `cardio:org-otsuka-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Otsuka+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Otsuka Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients (`cardio:ct-nct01439009`)
- Sponsors: A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration (`cardio:ct-nct02331680`)
- Sponsors: Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure (`cardio:ct-nct03772041`)
- Sponsors: A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia (`cardio:ct-nct04784442`)
- Sponsors: A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure \[CHF\]) (`cardio:ct-nct05615363`)

## Provenance

Content hash: b9d2e95cfce928c6f56292e6e8544176e19603c6245305c0b411526d42068e82
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
